Switzerland· 53553002
Insulin Lilly Humalog cartouches 3,0 ml, solution injectable
A insulin lispro product, registered in Switzerland by Eli Lilly (Suisse) SA and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Insulin lispro is registered in 11 of 19 countries.
Countries holding a registration under ATC A10AB04 (insulin lispro), each read from that country’s own register.
- This record: Switzerland
- 7 of them publish a price we can compare per daily dose
Insulin lispro · ATC A10AB04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
- Manufacturer
- Eli Lilly (Suisse) SA
- Country
- Switzerland (CH)
- ATC code
- A10AB04
- ATC class
- Insulin lispro
- Defined daily dose
- 40 E, P
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for insulin lispro.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Insulin lispro · interactions on record
434 records
- 15 severe
- 368 moderate
- 50 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- PrednisoloneA07EA01moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10AB04
Insulin lispro, as other registers publish it.
- Ireland100 units/mL Tempo Pen solution for injection in pre-filled penEli Lilly Nederland B.V.
- Ireland200 units/mL KwikPen solution for injection in pre-filled penEli Lilly Nederland B.V.
- CanadaADMELOGSANOFI-AVENTIS CANADA INC
- CanadaADMELOGSANOFI-AVENTIS CANADA INC
- CanadaADMELOG SOLOSTARSANOFI-AVENTIS CANADA INC
- FinlandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- PolandBysumlogGan & Lee Pharmaceuticals Europe GmbH
- IcelandBysumlogGan & Lee Pharmaceuticals Europe GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac200f26-b653-4b07-b205-e87b55999374 GET /v1/drugs/ac200f26-b653-4b07-b205-e87b55999374?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Biotechnologika"
}See everything about insulin lispro.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.